MKI67 and COVID-19: Taken together with little-to-no Ki-67 immunoreactivity and no detectable Ki-67+/CD68+ immunofluorescent signal, migration of microglial cells toward the site of injury appears to be the more likely mechanism occurring in COVID-19 inflammation, rather than microglial proliferation within affected regions.